| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 3, 2005
Accepted on July 20, 2005
The Ben May Institute for Cancer Research, The University of Chicago, Chicago, IL 60610
* To whom correspondence should be addressed. E-mail: ggreene{at}uchicago.edu.
Transcriptional activation of estrogen receptor alpha (ER
) is regulated by the ligand-dependent activation function AF-2 and the constitutively active N-terminal activation function AF-1. To identify ER
N-terminal-specific coregulators, we screened a breast cDNA library by T7 phage display and isolated histone deacetylase 4 (HDAC4). HDAC4 interacts with the ER
N-terminus both in vitro and in vivo. Presence of the ER
DNA binding domain and hinge region reduce HDAC4 recruitment while full length ER
enhances recruitment. HDAC4 interaction is selective for the ER
and not ER
N-terminus and occurs in the nucleus. We demonstrate in vivo that HDAC4 is recruited by the N-terminus to the promoter of an endogenous estrogen responsive gene. HDAC4 suppresses transcriptional activation of ER
by estrogen (E2) and selective ER modulators (SERMs) such as tamoxifen in a cell type-dependent manner. Consistently, silencing of HDAC4 promotes the agonist effect of SERMs (tamoxifen and raloxifene) in a cell type-specific manner. These findings indicate a role for HDAC4 in regulating ER
activity as a novel N-terminal coregulator and uncover a mechanism by which certain cell types regulate SERM behavior.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
A. Sayeed, S. D. Konduri, W. Liu, S. Bansal, F. Li, and G. M. Das Estrogen Receptor {alpha} Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis Cancer Res., August 15, 2007; 67(16): 7746 - 7755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kim, E. M. Woo, Y. T. E. Chong, D. R. Homenko, and W. L. Kraus Acetylation of Estrogen Receptor {alpha} by p300 at Lysines 266 and 268 Enhances the Deoxyribonucleic Acid Binding and Transactivation Activities of the Receptor Mol. Endocrinol., July 1, 2006; 20(7): 1479 - 1493. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |